Medtronic Medical Surgical — Net Sales increased by 0.1% to $2.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $2.07B to $2.17B. Over 4 years (FY 2021 to FY 2025), Medical Surgical — Net Sales shows relatively stable performance with a -2.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Increasing sales indicate strong market adoption and competitive success, while declining sales suggest market share loss or pricing pressure.
The total revenue generated from the sale of Medical Surgical products to customers, net of returns, allowances, and dis...
Comparable to segment-level revenue reported by diversified medical device competitors.
mdt_segment_medical_surgical_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.31B | $2.32B | $2.30B | $2.29B | $1.78B | $2.00B | $2.07B | $2.14B | $2.04B | $2.04B | $2.14B | $2.15B | $1.98B | $2.00B | $2.13B | $2.07B | $2.18B | $2.08B | $2.17B | $2.17B |
| QoQ Change | — | +0.6% | -1.0% | -0.4% | -22.2% | +12.4% | +3.4% | +3.2% | -4.4% | -0.2% | +5.1% | +0.3% | -8.1% | +1.1% | +6.6% | -2.6% | +5.4% | -4.6% | +4.2% | +0.1% |
| YoY Change | — | — | — | — | -22.8% | -13.8% | -10.0% | -6.7% | +14.8% | +1.9% | +3.5% | +0.5% | -3.4% | -2.1% | -0.7% | -3.5% | +10.5% | +4.4% | +2.0% | +4.9% |